Impact of natalizumab on patient-reported outcomes in multiple sclerosis: a longitudinal study. Stephenson JJ, Kern DM, Agarwal SS, Zeidman R, Rajagopalan K, Kamat SA, Foley J Health Qual Life Outcomes. 2012 Dec 27; 10(1):155. Epub 2012 Dec 27. PMID: 23270428. Abstract CommentRecommendBookmarkWatch